Stockscreener 앱 받기
224.95
0.10%
0.036
Resmed Inc 주식(RMD)의 최신 뉴스
National Pension Service Has $54.85 Million Stock Position in ResMed Inc. $RMD - MarketBeat
WINTON GROUP Ltd Makes New Investment in ResMed Inc. $RMD - MarketBeat
Why Is ResMed (NYSE:RMD) Suddenly Drawing Attention? - Kalkine Media
ResMed Stock Is Up 13% in Three Months, The Buyback Is Doing the Heavy Lifting. Here’s What It Could Be Worth Before 2027. - TIKR.com
ResMed Inc. stock extends eight-day slide as market value drops - ad-hoc-news.de
ResMed Stock Slides 8.6% Over 8 Straight Down Days - Trefis
ResMed stock heads into the open after a 0.2% dip - ad-hoc-news.de
Is ResMed (ASX:RMD) the Steadier Name in Healthcare? - Kalkine Media
ResMed Inc. stock dips as CEO share sale draws investor attention - ad-hoc-news.de
ResMed CEO Michael J. Farrell Executes Stock Options and Sells Shares Under 10b5-1 Plan - Kalkine Media
ResMed CEO Michael Farrell sells $1.11 million of company shares - investing.com
ResMed: A Significant Upside Despite The Perceived Risk (NYSE:RMD) - Seeking Alpha
ResMed CEO Michael Farrell sells $1.11 million of company shares By Investing.com - Investing.com India
ResMed (NYSE:RMD) CEO Michael Farrell Sells 4,991 Shares - MarketBeat
Are Resmed CDI (ASX:RMD) shares good value in 2026? - Rask Media
Citigroup Adjusts Price Target on ResMed to $240 From $235, Keeps Neutral Rating - marketscreener.com
Amundi Trims Holdings in ResMed Inc. $RMD - MarketBeat
ResMed stock heads into the open after a 3.3 percent slide - ad-hoc-news.de
Will ResMed Sleep Research Sharpen Its Case (ASX:RMD)? - Kalkine Media
ResMed Inc. stock falls after valuation warning but fundamentals stay solid - ad-hoc-news.de
ResMed Inc. $RMD Shares Purchased by California State Teachers Retirement System - MarketBeat
ResMed (ASX:RMD) Shares Retreat While FY26 Growth Remains in Focus - Kalkine
Resmed Inc Draws Eyes to Healthcare Pathway (ASX:RMD) - Kalkine Media
Is ResMed Inc (RMD) a Bargain After 3.2% Drop? GF Value Says Und - GuruFocus
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Farrell Peter C Disposes of 970 Shares in ResMed at $234.73 Each on September 2, 2026 - Kalkine Media
ResMed Inc. stock slips as Astral halt and GLP-1 worries weigh on sentiment - ad-hoc-news.de
Insider at ResMed (NYSE: RMD) lines up a million-dollar stock sale - Stock Titan
Resmed Inc Stock (RMD) Moved Down by 3.15% on Sep 8: What Investors Need To Know - TradingKey
Saudi Central Bank Increases Position in ResMed Inc. $RMD - MarketBeat
Wellington Management Group LLP Grows Stake in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Purchased by Hsbc Holdings PLC - MarketBeat
ResMed Inc. stock heads into the open after a 0.4% dip - ad-hoc-news.de
Why Is ResMed Inc. (ASX:RMD) Drawing Fresh Attention Among Healthcare Stocks? - Kalkine Media
How is ResMed (ASX:RMD) framing its sleep research push? - Kalkine Media
ResMed Inc. stock gains on FY2026 growth and buyback launch - ad-hoc-news.de
ResMed Inc Reports August 2026 CHESS Depositary Interests and Securities Update - Kalkine Media
Paralel Advisors LLC Purchases Shares of 10,293 ResMed Inc. $RMD - MarketBeat
ResMed Inc. (RMD) Stock Analysis: Navigating a 7.78% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
ResMed Inc. $RMD Shares Acquired by Giverny Capital Inc. - MarketBeat
ResMed Inc Discloses August 2026 CDI and Securities Statement - Kalkine
Why Is ResMed (ASX:RMD) Sustaining Home-Care Demand? - Kalkine Media
ResMed Director Peter Farrell Sells 970 Shares Under Rule 10b5-1 Plan - Kalkine
ResMed Inc. stock holds above support as fiscal 2026 growth and cautious 2027 outlook shape sentimen - AD HOC NEWS
ResMed Director Peter Farrell Executes Sale of 970 Shares via 10b5-1 Trading Plan - Kalkine Media
ResMed chairman emeritus Peter Farrell sells $227,688 in stock By Investing.com - Investing.com South Africa
ResMed (NYSE:RMD) Director Peter Farrell Sells 970 Shares - MarketBeat
ResMed chairman emeritus Peter Farrell sells $227,688 in stock - investing.com
ResMed (RMD) director sells shares under trading plan - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc.RMD - PR Newswire
Morgan Stanley Adjusts Price Target on ResMed to $225 From $227, Keeps Equalweight Rating - marketscreener.com
Nykredit A S Acquires New Position in ResMed Inc. $RMD - MarketBeat
ResMed (NYSE:RMD): A Quality Dividend Play Built on Sustainable Payouts - ChartMill
Jupiter Topco LLC Takes Position in ResMed Inc. $RMD - MarketBeat
Director at ResMed (NYSE: RMD) plans new 970-share stock sale - Stock Titan
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 9,064 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Sold by Van ECK Associates Corp - MarketBeat
ResMed Launches $450 Million Accelerated Share Repurchase - The Globe and Mail
ResMed (RMD) Announces $450 Million Accelerated Share Repurchase Agreement - GuruFocus
ResMed Enters $450 Million Accelerated Share Repurchase Agreement With Citibank; Shares Fall 3% - Moomoo
Is ResMed Inc (RMD) a Bargain After 3.6% Drop? GF Value Says Und - GuruFocus
ResMed Launches $450 Million Accelerated Share Buyback With Citibank - marketscreener.com
ResMed launches $450M accelerated share repurchase funded by MatrixCare sale proceeds - TradingView
ResMed (NYSE: RMD) plans to use MatrixCare sale cash for fast-track buyback - Stock Titan
Resmed Inc Stock (RMD) Moved Down by 3.25% on Sep 1: Facts Behind the Movement - TradingKey
Frazier Healthcare completes acquisition of MatrixCare from ResMed By Investing.com - Investing.com South Africa
MatrixCare software serves more than 15,000 providers. Frazier completes the acquisition. - Stock Titan
Quantitative Investment Management LLC Invests $2.21 Million in ResMed Inc. $RMD - MarketBeat
0.33%
0.20%
자본화:
|
볼륨(24시간):